Page last updated: 2024-11-07

2-(4-amidinophenyl)-1-benzofuran-5-carboxamidine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-(4-amidinophenyl)-1-benzofuran-5-carboxamidine: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID147287
CHEMBL ID354342
SCHEMBL ID5030472
MeSH IDM0142377

Synonyms (14)

Synonym
2-(4-carbamimidoylphenyl)benzofuran-5-carboxamidine
5-benzofurancarboximidamide, 2-[4-(aminoiminomethyl)phenyl]-
nsc240893
CHEMBL354342 ,
2-(4-carbamimidoylphenyl)-1-benzofuran-5-carboximidamide
2-(4-amidinophenyl)-1-benzofuran-5-carboxamidine
dapi-o
5-benzofurancarboximidamide, 2-(4-(aminoiminomethyl)phenyl)-
47165-00-4
SCHEMBL5030472
bdbm50009960
2-(4-amidinophenyl)-5-benzo[b]furancarboxamidine
2-(4-amidinophenyl)-1-benzo[b]furan-5-carboxamidine
DTXSID90963756
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (2)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Prothrombin Bos taurus (cattle)Ki11.30000.00112.06948.3700AID1132851
Glandular kallikreinSus scrofa (pig)Ki9.08002.70007.10339.5300AID1132853
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (4)

Processvia Protein(s)Taxonomy
proteolysisProthrombin Bos taurus (cattle)
acute-phase responseProthrombin Bos taurus (cattle)
positive regulation of blood coagulationProthrombin Bos taurus (cattle)
protein polymerizationProthrombin Bos taurus (cattle)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (4)

Processvia Protein(s)Taxonomy
serine-type endopeptidase activityProthrombin Bos taurus (cattle)
calcium ion bindingProthrombin Bos taurus (cattle)
protein bindingProthrombin Bos taurus (cattle)
fibrinogen bindingProthrombin Bos taurus (cattle)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (19)

Assay IDTitleYearJournalArticle
AID389464Antitrypanosomal activity against Trypanosoma brucei rhodesiense STIB 900 infected acute mouse model assessed as survival time at 1 mg/kg, ip administered daily for 4 days2008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Synthesis and antiprotozoal activity of cationic 2-phenylbenzofurans.
AID389454Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes2008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Synthesis and antiprotozoal activity of cationic 2-phenylbenzofurans.
AID1132857Anticoagulant activity in human plasma assessed as prolongation of partial thromboplastin time at 10'-5 M incubated for 30 secs (Rvb = 59 +/- 5.4 secs)1978Journal of medicinal chemistry, Jul, Volume: 21, Issue:7
Diarylamidine derivatives with one or both of the aryl moieties consisting of an indole or indole-like ring. Inhibitors of arginine-specific esteroproteases.
AID1132852Competitive reversible inhibition of bovine trypsin using alpha-N-benzoyl-DL-arginine-p-nitroanilide hydrochloride as substrate after 15 to 30 mins by Michaelis-Menten plot analysis1978Journal of medicinal chemistry, Jul, Volume: 21, Issue:7
Diarylamidine derivatives with one or both of the aryl moieties consisting of an indole or indole-like ring. Inhibitors of arginine-specific esteroproteases.
AID580533Antimicrobial activity against Bacillus anthracis Sterne spores by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
Novel broad-spectrum bis-(imidazolinylindole) derivatives with potent antibacterial activities against antibiotic-resistant strains.
AID580534Antimicrobial activity against Bacillus anthracis Sterne vegetative cells by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
Novel broad-spectrum bis-(imidazolinylindole) derivatives with potent antibacterial activities against antibiotic-resistant strains.
AID389451Selectivity index, ratio of IC50 for rat L6 cells to IC50 for Trypanosoma brucei rhodesiense STIB 9002008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Synthesis and antiprotozoal activity of cationic 2-phenylbenzofurans.
AID1132851Competitive reversible inhibition of bovine thrombin using alpha-N-benzoyl-DL-arginine-p-nitroanilide hydrochloride as substrate after 15 to 40 mins by Michaelis-Menten plot analysis1978Journal of medicinal chemistry, Jul, Volume: 21, Issue:7
Diarylamidine derivatives with one or both of the aryl moieties consisting of an indole or indole-like ring. Inhibitors of arginine-specific esteroproteases.
AID389452Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K12008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Synthesis and antiprotozoal activity of cationic 2-phenylbenzofurans.
AID53470Inhibitory dose against oncornaviral DNA polymerase activity of moloney murine leukemia virus1980Journal of medicinal chemistry, Jul, Volume: 23, Issue:7
Diaryl amidine derivatives as oncornaviral DNA polymerase inhibitors.
AID1132858Anticoagulant activity in human plasma assessed as prolongation of partial thromboplastin time at 5 x 10'-6 M incubated for 30 secs (Rvb = 59 +/- 5.4 secs)1978Journal of medicinal chemistry, Jul, Volume: 21, Issue:7
Diarylamidine derivatives with one or both of the aryl moieties consisting of an indole or indole-like ring. Inhibitors of arginine-specific esteroproteases.
AID389466Antitrypanosomal activity against Trypanosoma brucei rhodesiense STIB 900 infected acute mouse model assessed as survival time at 5 mg/kg, ip administered daily for 4 days2008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Synthesis and antiprotozoal activity of cationic 2-phenylbenzofurans.
AID389450Antitrypanosomal activity against Trypanosoma brucei rhodesiense STIB 900 bloodstream trypomastigotes2008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Synthesis and antiprotozoal activity of cationic 2-phenylbenzofurans.
AID389467Antitrypanosomal activity against Trypanosoma brucei rhodesiense STIB 900 infected acute mouse model assessed as survival time at 10 mg/kg, ip2008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Synthesis and antiprotozoal activity of cationic 2-phenylbenzofurans.
AID389453Selectivity index, ratio of IC50 for rat L6 cells to IC50 for chloroquine-resistant Plasmodium falciparum K12008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Synthesis and antiprotozoal activity of cationic 2-phenylbenzofurans.
AID1132856Anticoagulant activity in human plasma assessed as prolongation of partial thromboplastin time at 10'-4 M incubated for 30 secs (Rvb = 59 +/- 5.4 secs)1978Journal of medicinal chemistry, Jul, Volume: 21, Issue:7
Diarylamidine derivatives with one or both of the aryl moieties consisting of an indole or indole-like ring. Inhibitors of arginine-specific esteroproteases.
AID389449Cytotoxicity against rat L6 cells2008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Synthesis and antiprotozoal activity of cationic 2-phenylbenzofurans.
AID1132853Competitive reversible inhibition of porcine pancreatic kallikrein using alpha-N-benzoyl-DL-arginine-p-nitroanilide hydrochloride as substrate after 15 to 180 mins by Michaelis-Menten plot analysis1978Journal of medicinal chemistry, Jul, Volume: 21, Issue:7
Diarylamidine derivatives with one or both of the aryl moieties consisting of an indole or indole-like ring. Inhibitors of arginine-specific esteroproteases.
AID389455Selectivity index, ratio of IC50 for rat L6 cells to IC50 for Leishmania donovani MHOM/SD/62/1S-CL2D2008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Synthesis and antiprotozoal activity of cationic 2-phenylbenzofurans.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (60.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.34

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.34 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.14 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.34)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]